Neuroradiological aspects of multiple sclerosis [Neuroradiologische aspekte bei encephalitis disseminata]

被引：0
作者：
Reiche W. [1 ]
Merkelbach S. [2 ]
Reith W. [1 ]
机构：
[1] Abteilung für Neuroradiologie der Radiologischen Klinik, Universitätskliniken des Saarlandes, Homburg/Saar
[2] Neurologische Klinik, Universitätskliniken des Saarlandes, Homburg/Saar
来源：
Der Radiologe | 2000年 / 40卷 / 11期
关键词：
Magnetic resonance imaging (MRI); Multiple sclerosis; Neuroradiological diagnosis;
D O I：
10.1007/s001170050877
中图分类号：
学科分类号：
摘要：
Magnetic resonance imaging (MRI) has developed without doubt to the most important investigation method in multiple sclerosis. MRI is very sensitive to detect MS lesions but unfortunately of limited specificity. The purpose of this review is 1. to work UP the MRI characteristics of MS lesions, 2. to derive recommendations for MRT-protocolls for daily radiological work and 3. to discuss new MR developments. MS lesions in the acute inflammatory stage show first an enhancement of GD-DTPA due to break down of the blood brain barrier and develop a T2-hyperintensity due to an edema. The following disease course is categorized in a phase of reparation and remyelinisation respectively, of gliosis and a defect stage. MS-plaques in the remyelinisation and gliotic phase appear as hyperintens lesion on T2-weighted scans. Chronic MS lesions with a defect are also T2-hyperintens and demonstrate additionally due to severe axonal loss a hypointensity on short TR SE scans. MS lesions exhibit a characteristic distribution. They are found typically periventricular, in the corpus callosum and at the calloso-septal interface, cortico-subcortical and infratentorial. The most important MR criteria to predict conversion from suspected (CSMS) to clinical definite MS (CDMS) are GD-DTPA enhancement and juxtacortical lesion localisation followed by the parameter periventricular and infratentorial localisation. Based on guidelines for the use of MRI in drug studies and on equivalent recommendations for the routine diagnostic we suggest rational and economic MRT protocols for cerebral, spinal, and N. opticus investigations. Such standardised protocols shall help to make MRI investigations more efficient and better comparable. New MR developments include measurement of magnetisation transfer and T2-relaxation, diffusion weighted imaging, proton MR spectroscopy, and quantification of lesion load. These methods can analyse more specifically tissue changes in MS plaques and yet can reveal changes in normal appearing white matter.
引用
收藏
页码：1045 / 1056
页数：11
相关论文
共 56 条
[11]  
Fazekas F., Offenbacher H., Fuchs S., Schmidt R., Niederkorn K., Homer S., Lechner H., Criteria for an increased specifity of MRI interpretation in elderly subjects with suspected multiple sclerosis, Neurology, 38, pp. 1822-1825, (1988)
[12]  
Fazekas F., Barkhof F., Filippi M., Grossman R.I., Li D.K.B., McDonald W.I., Et al., The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis, Neurology, 53, pp. 448-456, (1999)
[13]  
Filippi M., Rovarius M., Campi A., Pereira C., Comi G., Semi-automated thresholding technique for measuring lesion volumes in multiple sclerosis: Effects of the change of the threshold on the computed lesion loads, Acta Neurol Scand, 93, pp. 30-34, (1996)
[14]  
Filippi M., Yousry T.A., Alkadhi H., Stehling M., Horsfield M.A., Volts R., Spinal cord MRI in multiple sclerosis with multicoil arrays: A comparison between fast spin echo and fast FLAIR, J Neurol Neurosurg Psychiatry, 61, pp. 632-635, (1996)
[15]  
Filippi M., Horsfield M.A., Ader H.J., Barkhof F., Bruzzi P., Evans A., Et al., Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis, Ann Neurol, 43, pp. 499-506, (1998)
[16]  
Filippi M., Rovaris M., Capra R., Gasperini C., Yousry T.A., Sormani M.P., Et al., A multicenter longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials, Brain, 121, pp. 2011-2020, (1998)
[17]  
Filippi M., Rocca M.A., Martino G., Horsfield M.A., Comi G., Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis, Ann Neurol, 43, pp. 809-814, (1998)
[18]  
Francis D.A., Compston D.A.S., Batchelosr J.R., McDonald W.I., A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up, J Neurol Neurosurg Psychiatry, 50, pp. 758-765, (1987)
[19]  
Hittmair K., Mallek R., Prayer D., Schindler E.G., Kollegger H., Spinal cord lesions in patients with multiple sclerosis: Comparison of MR pulse sequences, AJNR, 17, pp. 1555-1565, (1996)
[20]  
Horsfield M.A., Lai M., Webb S.L., Barker G.J., Tofts P.S., Turner R., Et al., Apparent diffusion coefficient's in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance, Magn Reson Imaging, 36, pp. 393-400, (1996)
123456